All In Biotech

Drug Trial Radar · NCT06204679

Pharmacokinetics of Fixed-Dose Combination Tablet of Bemnifosbuvir and Ruzasvir

A Phase 1, Open-Label Study to Assess Comparative Bioavailability and Effect of Food on a Prototype Fixed-Dose Combination of Bemnifosbuvir and Ruzasvir Versus Individual Dosage Forms Taken Concomitantly in Healthy Adult Subjects

Last checked: Nov 20, 2026Latest source record: Sep 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

42

Actual

Start

Dec 14, 2023

Primary completion

Aug 25, 2024

Study completion Aug 25, 2024

Sponsor

Lead sponsor
Atea Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Jan 12, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study will assess comparative bioavailability and effect of food on a prototype fixed-dose combination (FDC) of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in healthy subjects

Conditions

  • Healthy Volunteer Study

Interventions

  • Bemnifosbuvir (BEM)/Ruzasvir (RZR) FDC under fasting conditionsDrug

    A Fixed-Dose Combination of Bemnifosbuvir (BEM) and Ruzasvir (RZR)

  • Bemnifosbuvir (BEM)/Ruzasvir (RZR) FDC under fed conditionsDrug

    A Fixed-Dose Combination of Bemnifosbuvir (BEM) and Ruzasvir (RZR)

  • Bemnifosbuvir (BEM) and Ruzasvir (RZR) as reference formulation under fasting conditionsDrug

    Bemnifosbuvir (BEM) and Ruzasvir (RZR) as separate formulations

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pharmacokinetics (PK) of FDC compared to reference:(Cmax)Time frame: Day 1, Day 7, Day 13
  2. Pharmacokinetics (PK) of FDC compared to reference:(AUC)Time frame: Day 1, Day 7, Day 13
  3. Food effect of Fixed Dose Combination of Bemnifosbuvir (BEM)/Ruzasvir (RZR):(Cmax)Time frame: Day 1, Day 7, Day 13
  4. Food effect of Fixed Dose Combination of Bemnifosbuvir (BEM)/Ruzasvir (RZR):(AUC)Time frame: Day 1, Day 7, Day 13

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Atea Study Site

    Cypress, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.